Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis
| dc.contributor.author | Michelsen, Brigitte | |
| dc.contributor.author | Ørnbjerg, Lykke Midtbøll | |
| dc.contributor.author | Kvien, Tore K | |
| dc.contributor.author | Pavelka, Karel | |
| dc.contributor.author | Nissen, Michael J | |
| dc.contributor.author | Nordström, Dan | |
| dc.contributor.author | Santos, Maria José | |
| dc.contributor.author | Koca, Suleyman Serdar | |
| dc.contributor.author | Askling, Johan | |
| dc.contributor.author | Rotar, Ziga | |
| dc.contributor.author | Gudbjornsson, Bjorn | |
| dc.contributor.author | Codreanu, Catalin | |
| dc.contributor.author | Loft, Anne Gitte | |
| dc.contributor.author | Kristianslund, Eirik Klami | |
| dc.contributor.author | Mann, Herman F | |
| dc.contributor.author | Ciurea, Adrian | |
| dc.contributor.author | Eklund, Kari K | |
| dc.contributor.author | Vieira-Sousa, Elsa | |
| dc.contributor.author | Yazici, Ayten | |
| dc.contributor.author | Jacobsson, Lennart | |
| dc.contributor.author | Tomšič, Matija | |
| dc.contributor.author | Löve, Thorvardur Jón | |
| dc.contributor.author | Ionescu, Ruxandra | |
| dc.contributor.author | van der Horst-Bruinsma, I E | |
| dc.contributor.author | Iannone, Florenzo | |
| dc.contributor.author | Pombo-Suarez, Manuel | |
| dc.contributor.author | Jones, Gareth T | |
| dc.contributor.author | Hyldstrup, Lise Hejl | |
| dc.contributor.author | Krogh, Niels Steen | |
| dc.contributor.author | Hetland, Merete Lund | |
| dc.contributor.author | Østergaard, Mikkel | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Epidemiology Group | en |
| dc.contributor.institution | University of Aberdeen.Aberdeen Centre for Arthritis and Musculoskeletal Health (ACAMH) | en |
| dc.date.accessioned | 2021-01-20T00:09:10Z | |
| dc.date.available | 2021-01-20T00:09:10Z | |
| dc.date.embargoedUntil | 2021-01-20 | |
| dc.date.issued | 2020-09-01 | |
| dc.description | Funding: This work was supported by Novartis. Novartis had no influence on the data collection, statistical analyses, manuscript preparation or decision to submit. | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 7 | |
| dc.format.extent | 386583 | |
| dc.format.extent | 321410 | |
| dc.format.extent | 267148 | |
| dc.format.extent | 241603 | |
| dc.identifier | 157422171 | |
| dc.identifier | d93f70e3-1f02-45f2-94ae-d77713688b73 | |
| dc.identifier | 31960053 | |
| dc.identifier | 85090080184 | |
| dc.identifier | 000574394600043 | |
| dc.identifier.citation | Michelsen, B, Ørnbjerg, L M, Kvien, T K, Pavelka, K, Nissen, M J, Nordström, D, Santos, M J, Koca, S S, Askling, J, Rotar, Z, Gudbjornsson, B, Codreanu, C, Loft, A G, Kristianslund, E K, Mann, H F, Ciurea, A, Eklund, K K, Vieira-Sousa, E, Yazici, A, Jacobsson, L, Tomšič, M, Löve, T J, Ionescu, R, van der Horst-Bruinsma, I E, Iannone, F, Pombo-Suarez, M, Jones, G T, Hyldstrup, L H, Krogh, N S, Hetland, M L & Østergaard, M 2020, 'Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis', Rheumatology, vol. 59, no. 9, pp. 2455-2461. https://doi.org/10.1093/rheumatology/kez656 | en |
| dc.identifier.doi | 10.1093/rheumatology/kez656 | |
| dc.identifier.iss | 9 | en |
| dc.identifier.issn | 1462-0324 | |
| dc.identifier.other | ORCID: /0000-0003-0016-7591/work/83703930 | |
| dc.identifier.uri | https://hdl.handle.net/2164/15696 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85090080184&partnerID=8YFLogxK | en |
| dc.identifier.vol | 59 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Rheumatology | en |
| dc.subject | axial spondyloarthritis | en |
| dc.subject | psoriatic arthritis | en |
| dc.subject | TNF inhibitors | en |
| dc.subject | treatment outcomes | en |
| dc.subject | PHYSICIAN | en |
| dc.subject | PSORIATIC-ARTHRITIS | en |
| dc.subject | R Medicine | en |
| dc.subject | Pharmacology (medical) | en |
| dc.subject | Rheumatology | en |
| dc.subject | Supplementary Data | en |
| dc.subject.lcc | R | en |
| dc.title | Impact of discordance between patient's and evaluator's global assessment on treatment outcomes in 14 868 patients with spondyloarthritis | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 4 of 4
- Name:
- Michelsen_etal_Rheum_Impact_of_discordance_AAM.pdf
- Size:
- 377.52 KB
- Format:
- Adobe Portable Document Format
- Name:
- Figure_1_AAM.jpg
- Size:
- 235.94 KB
- Format:
- Joint Photographic Experts Group/JPEG File Interchange Format (JFIF)
